Literature DB >> 21631975

Factors associated with postoperative complications and mortality in perforated peptic ulcer.

Eduardo Esteban Montalvo-Javé1, Omar Corres-Sillas, César Athié-Gutiérrez.   

Abstract

BACKGROUND: Elective surgery for uncomplicated peptic ulcer has shown a significant decrease; however, complications such as perforation and obstruction persist and require urgent surgical management. The aim of this study was to identify factors associated with early postoperative complications and mortality of patients admitted to the emergency department with perforated peptic ulcer.
METHODS: We performed a clinical, retrospective, cross-sectional and descriptive study of patients who were treated at the General Hospital of Mexico with a diagnosis of perforated peptic ulcer from January 2006 to December 2008. Thirty patients were included in the study. We studied several clinical findings upon admission to the emergency department and intraoperative patient findings in order to determine the association of those with early postoperative complications and mortality.
RESULTS: We studied 30 patients with an average age of 57.07 years (± 14.2 years). The male:female ratio was 2:1. We found that the risk of developing postoperative complications was 66.7% and is significantly influenced by time of onset of abdominal pain prior to admission, bloating, septic shock and blood type O positive. Mortality was 16.7% and was correlated with the presence of septic shock on admission. The surgical procedure performed was primary closure with Graham patch in 86.6%. Average hospital stay was 12.8 days.
CONCLUSIONS: The presence of early postoperative complications is associated with time of onset of abdominal pain before admission, abdominal distension, blood type O positive and the presence of septic shock on admission.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631975

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  7 in total

1.  Perforations of the esophagus and stomach: what should I do?

Authors:  Francesca Dimou; Vic Velanovich
Journal:  J Gastrointest Surg       Date:  2014-12-02       Impact factor: 3.452

2.  Over-the-scope-clip applications for perforated peptic ulcer.

Authors:  Jing-Jing Wei; Xue-Ping Xie; Ting-Ting Lian; Zhi-Yong Yang; Yu-Feng Pan; Zhen-Lv Lin; Guang-Wei Zheng; Ze-Hao Zhuang
Journal:  Surg Endosc       Date:  2019-02-25       Impact factor: 4.584

3.  Preoperative factors influencing mortality and morbidity in peptic ulcer perforation.

Authors:  P Sivaram; A Sreekumar
Journal:  Eur J Trauma Emerg Surg       Date:  2017-03-03       Impact factor: 3.693

4.  Clinical presentation and surgical management of perforated peptic ulcer in a tertiary hospital in Mogadishu, Somalia: a 5-year retrospective study.

Authors:  Abdihamid Mohamed Ali; Abdulkadir Nor Mohamed; Yahye Garad Mohamed; Salim İdris Keleşoğlu
Journal:  World J Emerg Surg       Date:  2022-05-16       Impact factor: 8.165

5.  Clinical profile and outcome of surgical treatment of perforated peptic ulcers in Northwestern Tanzania: A tertiary hospital experience.

Authors:  Joseph B Mabula; Mheta Koy; Mabula D Mchembe; Hyasinta M Jaka; Rodrick Kabangila; Alphonce B Chandika; Japhet M Gilyoma; Phillipo L Chalya
Journal:  World J Emerg Surg       Date:  2011-08-26       Impact factor: 5.469

6.  Postoperative Morbidity and Mortality of Perforated Peptic Ulcer: Retrospective Cohort Study of Risk Factors among Black Africans in Côte d'Ivoire.

Authors:  Soro Kountele Gona; Mahassadi Kouamé Alassan; Koffi Gnangoran Marcellin; Kissi Ya Henriette; Coulibaly Adama; Assohoun Toussaint; Ehua Adjoba Manuela; Seu Gagon Sylvain; Afum-Adjei Awuah Anthony; Ehua Somian Francis
Journal:  Gastroenterol Res Pract       Date:  2016-01-26       Impact factor: 2.260

Review 7.  Scoring systems for outcome prediction in patients with perforated peptic ulcer.

Authors:  Kenneth Thorsen; Jon Arne Søreide; Kjetil Søreide
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-10       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.